Press
-
A Master Regulator of Gene Expression
January 31, 2024
-
Charlie is on the 2023 list of 'Most Highly Cited' researchers in the world
-
A CRISPR-based platform identified many genes that could ptentially improve T-cell therapies for cancer treatment
November 9, 2023
-
Charlie is elected to the National Academy of Inventors
December 12, 2022
-
Charlie and Pratiksha are among the ‘Most Cited Scientists’
November 15, 2022
-
Tune Therapeutics is one of Nature Biotechnology’s academic spinouts of 2021
November 3, 2022
-
The Gersbach lab is awarded funding from the Gilbert Family Foundation to develop genome editing therapies for Neurofibromatosis
April 28, 2022
-
Nature Biotech highlights the therapeutic potential of epigenome editing
March 19, 2022
-
Tune Therapeutics launches to develop a new class of gene and cell therapies based on epigenomic control
December 2, 2021
-
Charlie is on the 2021 list of the World’s Most Highly Cited Scientists
November 16, 2021
-
Duke receives two new NIH funded centers to explore genomic variation
September 9, 2021
-
Our work developing new mouse models for CRISPR-based epigenome editing is published in Nature Methods
August 3, 2021
-
Charlie Awarded Distinguished Professorship
July 10, 2021
-
New Collaborative Grant to Study Genetics of Neuropsychiatric Disorders
May 5, 2021
-
Charlie is Recognized as 2020 Highly Cited Researcher
November 18, 2020
-
NIH Grant Creates First Duke Center of Excellence in Genome Sciences
September 24, 2020
-
Gersbach lab research highlighted by Vice President of Research
April 14, 2020
-
Duke Researchers Garner Over $6M in NIH Funding to Fight Genetic Diseases
January 3, 2020
-
Charlie Recognized as 2019 Highly Cited Researcher
-
The Evolution of Genetic Engineering: A Q&A with Charles Gersbach
November 4, 2019
-
Weapon of Mass Congestion: Protection from Influenz Virus through Gene Control
October 14, 2019
-
New Duke Center Takes Aim at the Dark Genome
October 1, 2019
-
New CRISPR Class Expands Genetic Engineering Toolbox
-
Engineering "Hairpins" Increases CRISPR Accuracy
-
More Progress Toward Gene Editing for Kids with Muscular Dystrophy
February 26, 2019
-
Single Genetic Editing Treatment Provides Long-Term Benefits in Mice
February 18, 2019
-
Researchers Engineer Epigenome Editors to Study How Gene Expression Affects Disease
January 1, 2019
-
Gersbach awarded gene therapy research grant from Gilbert Family Foundation
December 17, 2018
-
Three Duke Seniors Named Rhodes Scholars: Ariel Kantor, Gersbach lab undergraduate researcher
November 18, 2018
-
From Innovation to Impact
October 19, 2018
-
Exploring the Mechanics of Gene Expression
September 16, 2018
-
Gersbach Named Allen Distinguished Investigator
June 15, 2017
-
CRISPR/Cas9 Silences Gene Associated with High Cholesterol
April 17, 2018
-
UCB Strengthens Research Capabilities With Acquisition of Element Genomics, a Duke University Biotech Spin-off
April 5, 2018
-
Betting on the first disease to be treated by gene editing
March 15, 2017
-
Our genome editing work is highlighted by The Scientist in an article on the history of the technologies
October 2, 2016
-
With CRISPR, Scientists Make Neurons From Fibroblasts
-
Command and cure: We don't need to edit genomes to control them
June 15, 2016
-
The CRISPR Way to Think about Duchenne’s
April 28, 2016
-
Gene Editing Offers Hope for Treating Duchenne Muscular Dystrophy, Studies Find
-
Epigenetics: The genome unwrapped
December 2, 2015
-
A Powerful New Way to Edit DNA
March 4, 2014
-
Comparing Genome Editing Technologies
March 1, 2014
-
Right on target: New era of fast genetic engineering
January 22, 2014
-
The CRISPR Craze
August 23, 2013